These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13947690)

  • 1. [Activation of fibrinolysis by 3-pyridylacetic acid and nicotinic acid in man].
    GIBELLI A; SACCHETTI G; MAINIERI L; SOARDI F
    Acta Vitaminol; 1962; 16():107-19. PubMed ID: 13947690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the metabolism of nicotinic acid and of one of its higher homologues, 3-pyridylacetic acid, administered in massive doses in man. I. Experiments with nicotinic acid].
    MAINARDI L
    Acta Vitaminol; 1960 Dec; 14():261-7. PubMed ID: 13765467
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the activation of fibrinolysis by administration of nicotinic acid].
    IMHOF P; IMHOF M; EICHENBERGER E; LAUENER H
    Schweiz Med Wochenschr; 1959 Jul; 89():736-40. PubMed ID: 13852757
    [No Abstract]   [Full Text] [Related]  

  • 4. [RESEARCH ON INFLUENCE OF VASCULO-TISSUE FACTORS ON COAGULATION AND FIBRINOLYSIS. VI. LOCAL ACTIVATION AND GENERAL ACTIVATION OF FIBRINOLYSIS DIVERSITY OF RESPONSIBLE FACTORS].
    NERISERNERI GG; ROSSIFERRINI PL; PAOLETTI P; SILVESTRINI E
    Riv Crit Clin Med; 1964 Dec; 64():630-40. PubMed ID: 14320090
    [No Abstract]   [Full Text] [Related]  

  • 5. [VALUE OF THROMBELASTOGRAPHY IN THERAPEUTIC FIBRINOLYSIS OBTAINED USING A NICOTINIC ACID DERIVATIVE].
    PERRETTA A; PARANO JR; VILLA JJ
    Prensa Med Argent; 1964 Aug; 51():427-31. PubMed ID: 14193347
    [No Abstract]   [Full Text] [Related]  

  • 6. [FURTHER THERAPEUTIC POSSIBILITIES FOR PERIPHERAL CIRCULATION DISTURBANCES WITH SPECIAL REGARD TO FIBRINOLYSIS ACTIVATION].
    LUCZAK S
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1964 Nov; 308():841-3. PubMed ID: 14347791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of nicotinic acid on the fibrinolytic activity of the blood in atherosclerosis].
    SHERSHEVSKII MG
    Kardiologiia; 1963; 3():64-8. PubMed ID: 13977201
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various trials on the effect of nicotinic acid and Complamin on fibrinolysis].
    MOERS AM; den OTTOLANDER GJ
    Ned Tijdschr Geneeskd; 1962 Jun; 106():1221-5. PubMed ID: 14475011
    [No Abstract]   [Full Text] [Related]  

  • 9. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man.
    GINOULHIAC E; TENCONI LT; CHIANCONE FM
    Nature; 1962 Mar; 193():948-9. PubMed ID: 13898750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic action of nicotinic acid].
    MARRAZZA P; LUCA S
    Acta Vitaminol; 1960 Oct; 14():207-9. PubMed ID: 13767111
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 13. [EXTENDED THERAPEUTIC POSSIBILITIES IN PERIPHERAL CIRCULATORY DISORDERS WITH SPECIAL RESPECT TO FIBRINOLYSIS ACTIVATION].
    LUCZAK S
    Chirurg; 1964 Dec; 35():546-8. PubMed ID: 14342271
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity.
    WILSON WL; FOSTIROPOULOS G
    Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147
    [No Abstract]   [Full Text] [Related]  

  • 15. [3-Pyridylacetic acid: drug kinetics and relations with the metabolism of nicotinic acid].
    GINOULHIAC E; TENCONI LT
    Minerva Med; 1960 Apr; 51():1166-9. PubMed ID: 13850212
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of thrombolytic activity.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():238-9. PubMed ID: 13996900
    [No Abstract]   [Full Text] [Related]  

  • 17. [INDIRECT FIBRINOLYSIS AS A THERAPEUTIC PRINCIPLE IN THE TREATMENT OF ATHEROSCLEROSIS].
    SCHULZE G; POLIVODA H; KOESTERING H
    Munch Med Wochenschr; 1963 Aug; 105():1692-7. PubMed ID: 14046797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transformation of 3-hydroxy anthramilic acid into quinolinic acid and into nicotinic acid].
    SCARDI V; VIRGILIO A
    Boll Soc Ital Biol Sper; 1953 Jan; 29(1):31-4. PubMed ID: 13066644
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES.
    WEINER M
    Am J Med Sci; 1963 Sep; 246():294-300. PubMed ID: 14063746
    [No Abstract]   [Full Text] [Related]  

  • 20. [A precis regarding the hypocholesterolemic activities of nicotinic acid and 3-pyridineacetic acid].
    ALTSCHUL R
    Minerva Med; 1963 Jul; 54():1969-71. PubMed ID: 14012352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.